1999/129/EC: Commission Decision of 29 January 1999 amending for the second time Decision 94/381/EC concerning certain protection measures with regard to bovine spongiform encephalopathy and the feeding of mammalian derived protein (notified under document number C(1999) 198) (Text with EEA relevance)
Published date | 16 February 1999 |
Subject Matter | Veterinary legislation |
Official Gazette Publication | Official Journal of the European Communities, L 41, 16 February 1999 |
1999/129/EC: Commission Decision of 29 January 1999 amending for the second time Decision 94/381/EC concerning certain protection measures with regard to bovine spongiform encephalopathy and the feeding of mammalian derived protein (notified under document number C(1999) 198) (Text with EEA relevance)
Official Journal L 041 , 16/02/1999 P. 0014 - 0015
COMMISSION DECISION of 29 January 1999 amending for the second time Decision 94/381/EC concerning certain protection measures with regard to bovine spongiform encephalopathy and the feeding of mammalian derived protein (notified under document number C(1999) 198) (Text with EEA relevance) (1999/129/EC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Directive 90/425/EEC of 26 June 1990 concerning veterinary and zootechnical checks applicable in intra-Community trade in certain live animals and products with a view to the completion of the internal market (1), as last amended by Directive 92/118/EEC (2), and in particular Article 10(4) thereof,
Whereas Commission Decision 94/381/EC (3) concerning certain protection measures with regard to bovine spongiform encephalopathy and the feeding of mammalian derived protein as amended by Decision 95/60/EC (4), prohibits the feeding of protein derived from all mammalian species to ruminants; whereas certain animal products and by-products may be exempted from this prohibition;
Whereas the Scientific Steering Committee adopted a report and scientific opinion on the safety of hydrolysed proteins produced from bovine hides on 22 and 23 October 1998; whereas this opinion addresses the questions of under which conditions of sourcing of the material and/or of type of material used and/or production process can hydrolysed proteins, produced from bovine hides destined for animal consumption, be considered free of BSE infectivity; whereas the Scientific Steering Committee in the above opinions strongly recommends that hydrolysed proteins manufacturers implement and respect hazard analysis and critical control points procedures;
Whereas the Commission has adopted Decision 97/534/EC (5) as last amended by Council Decision 98/745/EC (6) on the prohibition of the use of material presenting risks as regards transmissible spongiform encephalopathies;
Whereas the Commission has adopted Decision...
To continue reading
Request your trial